Gene silencing through RNAi has emerged as a powerful tool for genetic loss-of-function studies. In 2009, the NIH Scientific Directors approved the establishment of a genome-wide RNAi screening facility to perform collaborative projects with intramural investigators, to be housed at the NIH Chemical Genomics Center (NCGC). To date, infrastructure and procedures for high [...]
